chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; Diarrhea; Gas; Stomach Rumbling; Nausea; Severe Injection Site Pain; This spontaneous case was reported by an occupational therapist and describes the occurrence of DIARRHOEA (Diarrhea), FLATULENCE (Gas), ABDOMINAL DISCOMFORT (Stomach Rumbling), NAUSEA (Nausea) and INJECTION SITE PAIN (Severe Injection Site Pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), FLATULENCE (Gas), ABDOMINAL DISCOMFORT (Stomach Rumbling), NAUSEA (Nausea) and INJECTION SITE PAIN (Severe Injection Site Pain). On 16-Jan-2021, the patient experienced HEADACHE (Headache). On 15-Jan-2021, INJECTION SITE PAIN (Severe Injection Site Pain) had resolved. On 16-Jan-2021, HEADACHE (Headache) had resolved. At the time of the report, DIARRHOEA (Diarrhea), FLATULENCE (Gas), ABDOMINAL DISCOMFORT (Stomach Rumbling) and NAUSEA (Nausea) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
increased (rapid) heartrate at rest, an hour following administration of vaccine. Symptom persisted for half an hour, followed by flushing of the face and slight nausea.
abdominal discomfort; diarrhea; sore throat; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 20Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL DISCOMFORT (non-serious), outcome "unknown", described as "abdominal discomfort"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat".  No follow-up attempts are possible. Information on lot/ batch number cannot be obtained. No further information is expected.
In January of 2022 I was diagnosed with Covid.  After it passing fairly uneventfully, I was diagnosed with Pneumonia in February, unrelated to covid.  During that time while I was till in the covid recovery peirod my atrial flutter returned.  I started having edema again and had to be put back on anti coagulants a diuretics.
Patient experienced a rash at the site of her Zostavax vaccination. At a 2 week follow up the rash has subsided.
Information has been received form a physician concerning a 12 year old female who on 02-OCT-2007 was vaccinated with a third dose of GARDASIL. On 03-OCT-2007 the patient experienced red blotchy rash, red pauples on her forehead and cheeks with a facial swelling. On 04-OCT-2007 seen in the physician's office. Treated with BENADRYL. No adverse experiences noted from the first two doses. The patient's outcome was unknown. NO product quality complaint was involved. Additional information has been requested.
Feverish, nausea, body aches, pain/swelling and bruising at injection site, hurts from left side of face and ears down to wrist and back to shoulder blade on left side, hurts under left arm pit, tired, soreness in whole body
WALKING ZOMBIE FOR 2 WEEKS WHICH I HAVE NO MEMORY OF; HUSBAND HAD TO HELP ME BATH, DRESS ETC.; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced walking zombie for 2 weeks which i have no memory of, and husband had to help me bath, dress etc.. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from walking zombie for 2 weeks which i have no memory of, and husband had to help me bath, dress etc. This report was non-serious.
Shortness of breath and chest pains (left side) ; urgent care-> abnormal EKG, Emergency Room of hospital, admitted, additional testing and observation, procedures, and diagnosed Acute Pericarditis - shortness of breadth June 16, 2021, chest pains June 17, 2021, visit to primary care June 18, 2021, additional chest pains June 19/June 20, 2021 middle of the night, urgent care June 20, 2021, tested, observed, treatment started, released June 21 evening.
low-grade fever; This is a spontaneous report from a Pfizer-sponsored program  Support. A contactable Male consumer (Patient) reported that:  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration, on 18Mar2021, as a dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient historical vaccine includes BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration, on 25Feb2021, as a dose 1, single for COVID-19 immunization. On 19Mar2021, the patient experiences a low-grade fever. Outcome of the event was unknown.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Patient received first dose of H1N1 on 11/18/2009 and second on 12/02/2009
Client reports having a reaction to her first two doses of Moderna vaccine but medically advised she could get the booster dose but keep in mind she may have a similar reaction. She expressed understanding this risk but felt the booster was necessary in order to complete an upcoming trip to visit her sister who has cancer and is immunocompromised.   With both previous doses, client reports feeling the medicine come over her body rapidly, with a sensation of being "drugged." Client reports PMH of addiction. 22 years sober. In both of those doses, the sensation was weak enough that she was able to drive home after each dose, waiting 15 minutes for first dose and 30 minutes for second dose. With the first dose, she reports feeling at baseline for the most part but developed swelling and redness at the vaccine site 10 days after administration, along with redness and swelling at her palms of hands and soles of feet. With second dose, she felt feeling of being drugged but was able to drive home before symptoms worsened at 45 minutes. Those symptoms continued for 48 hours then self resolved.  Today - Received dose at 1520. Notable shooting pain from vaccine site at L deltoid down arm to L hand. Within 10 seconds, reported numbness and tingling in LUE. Within 1 minute of administration, client felt a daze that decreased level of consciousness similar to a feeling of being "high."  Arm numbness continued along with HA that started at back of neck and move to bilateral temples of head after 20 minutes. Pt declined heat, ice, water or lotion. RN provided lymph massage to increase sensation and blood flow to L hand. VS stable at 120-130/80s with HR 70-90. Pulses +2 bilaterally with increased warmth and redness to bilateral palms.  Benadryl administered at 1550. Decreased fine motor skills noted while patient trying to hold and take pill. Notable difference in sensation between upper extremities with 3-4/5 strength and numbness in LUE and 5/5 strength with normal sensation in RUE. No change in symptoms after 45 minutes post Benadryl administration.  At 1620, patient stated she wants to go home and noted that she would decline an ambulance if one was provided.   Dr. assessed patient at 1640. Observed decreased LOC, strength and unstable gait. Offered to   She has two coworkers who volunteered to drive her home in her car from her appointment. 1710 declined transport to hospital. Discussed rule out for COVID vaccine reaction vs TIA  Spoke to fiancee regarding assuming responsibilities if brought home instead of ED. Fiancee agreed to assuming care.  Patient signed AMA form at 1715 against instruction by medical team to seek emergent care for symptoms. Escorted by clinic director and RN in wheelchair to patient's ride at 1730.
About 2 hours after I received vaccine, I started experiencing some dizziness.  This has gotten more severe over the past 2 days. can't walk, drive, or sometimes even sit without the room seeming to start spinning.; About 2 hours after I received vaccine, I started experiencing some dizziness.  This has gotten more severe over the past 2 days.  I now can't walk, drive, or sometimes even sit without the room seemi; About 2 hours after I received vaccine, I started experiencing some dizziness.  This has gotten more severe over the past 2 days.  I now can't walk, drive, or sometimes even sit without the room seemi; nausea; This is a Spontaneous report from a contactable Other-HCP (Patient).  The 56-years-old (non-pregnant) female patient received dose 1 of bnt162b2 (COMIRNATY, solution for injection) (Batch/Lot Number: EN6208) on 24Mar2021 at 09:45 (at the age of 56-years-old) via an unspecified route of administration in right arm at single dose for COVID-19 immunisation. The patient medical history included type 2 diabetes, HTN, restless leg syndrome. The concomitant medication included Humalog insulin, Lexapro, Trulicity, Farxiga. Patient had allergies to Sulfa drugs, victoza, augmenten. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24-MAR-2021, about 2 hours after the vaccination the patient experienced some dizziness which had become more severe over next 2 days. It was reported that the patient could not walk, drive, or sometimes even sit without the room seeming to start spinning.  Patient had fallen in yard due to dizziness about 24 hours after the vaccine. Patient went to doctor or other healthcare professional office/clinic visit for further care. She felt like if the dizziness gets even a little bit more severe patient might go to the emergency room. Patient had nausea with severe dizziness. Patient was not diagnosed with COVID-19 Prior or since vaccination. The outcome of the event was Not recovered.  Information on the lot/batch number has been requested.
Numbness in L hand  developing 3 hours after the second dose, which occurred while I was asleep and then woke up and then went away  within  5 minutes. Today,  1/18/2020, I developed dark red blotches on my L hand, especially visible near the knuckles (the metacarpophalangeal joints). It then went away  within 3 minutes but then appeared on other parts of my hand, including on my  R hand. The blotches all went away within 2-3 minutes but occurred consecutively in different parts of my hand (i.e., some area developed the blotchiness prior to others, and then other parts developed it)
On physical eversion pain occurred in upper abdomen, rest would make it go away, Over time (two weeks) the pain moved up through the lower chest, the upper chest, shoulders, the into my upper arms.   To date (9/24/2021) the pain has not gone away it is still in my upper arms , lower arms, and fingers.
Pain in right lower leg lead to hospitalization for a blood clot. Patient discharged on Eliquis.
Information has been received from a consumer concerning her 18 year old granddaughter who on an unspecified date was vaccinated with a dose of GARDASIL (route, dose not reported). Subsequently the patient experienced vasculitis. It is unknown if the patient sought medical attention. Follow-up information was received from the grandmother who reported that her granddaughter was currently having a fourth "vasculitis attack". She had not sought medical attention for the most recent "attack". In the past, the pediatrician had prescribed a steroid cream for her symptoms. Additional information has been requested.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4359071-00 (AbbVie). A 66-year-old female patient received BNT162b2 (BNT162B2), on 12Feb2021 as dose 1, single (Batch/Lot number: unknown), on 11Mar2021 as dose 2, single (Batch/Lot number: unknown) and on 11Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 65 years, all intramuscular for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "caught covid after getting booster". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I had a breakthrough case of Covid-19 where I had nausea dizziness loss of hearing in right ear.
inflammation of right arm; can't put on a shirt by herself, can't lift arm or reach for anything on a shelf; Felt like bursitis or crippling arthritis in upper arm in biceps area; Felt like bursitis or crippling arthritis in upper arm in biceps area; can't lift arm or reach for anything on a shelf, excruciating pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Nov2022 at 14:30 as dose 1, single (Batch/Lot number: unknown) at the age of 70 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing), notes: If COVID prior vaccination Yes. Concomitant medication(s) included: SERTRALINE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; TRELEGY; ATORVASTATIN. The following information was reported: BURSITIS (non-serious), ARTHRITIS (non-serious) all with onset 20Nov2022, outcome "not recovered" and all described as "Felt like bursitis or crippling arthritis in upper arm in biceps area"; PAIN IN EXTREMITY (non-serious) with onset 20Nov2022, outcome "not recovered", described as "can't lift arm or reach for anything on a shelf, excruciating pain"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset 20Nov2022, outcome "not recovered", described as "can't put on a shirt by herself, can't lift arm or reach for anything on a shelf"; INFLAMMATION (non-serious) with onset 20Nov2022, outcome "not recovered", described as "inflammation of right arm". Therapeutic measures were not taken as a result of inflammation, joint range of motion decreased, pain in extremity, bursitis, arthritis. Additional information: The patient experienced inflammation of right arm, 5 days after vaccine, can't put on a shirt after vaccine, can't put on a shirt by herself, can't lift arm or reach for anything on a shelf, excruciating pain, felt like she tore something inside her arm. Felt like bursitis or crippling arthritis in upper arm in biceps area. The patient has not recovered. No treatment was given. Additional information: The patient was not COVID tested post vaccination. The patient has no known allergies. The patient had no other vaccine in four weeks.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
"little reaction"; This spontaneous case was reported by a patient and describes the occurrence of ADVERSE REACTION ("little reaction") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION ("little reaction"). At the time of the report, ADVERSE REACTION ("little reaction") outcome was unknown. Not Provided          No concomitant medications reported by investigator No treatment medications provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
I woke up this morning with my hands swollen and bumpy with a red, rough rash. They do not itch.
I had backpain and headache; sore throat; fatigue and abdominal pain. They all lasted about the same amount of times. I had the symptoms for two days by the time I talked toUrgent Care ,  doctor on the 25th  - telehealth visit. She authorized a COVID test for me. I ended up having the symptoms for four or five days total. No treatment. I got extra rest. I didn't miss work - except for the couple hours to get my COVID test. I just felt crummy working from home.
On Friday, he had a runny nose. Then, he had a cough, congestion, fever, and vomiting over a 4 days period. He still has a cough and some lingering congestion. He had to miss 2 weekends of sports and a week of school.
Frozen shoulder; chills; FEVER; headache; itching head; injection site pain; neck stiffness; body ache; unable to sleep all night; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (neck stiffness), PAIN (body ache), INSOMNIA (unable to sleep all night), PERIARTHRITIS (Frozen shoulder) and CHILLS (chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (neck stiffness), PAIN (body ache), INSOMNIA (unable to sleep all night), CHILLS (chills), PYREXIA (FEVER), HEADACHE (headache), PRURITUS (itching head) and VACCINATION SITE PAIN (injection site pain). On an unknown date, the patient experienced PERIARTHRITIS (Frozen shoulder). The patient was treated with CORTISONE for Frozen shoulder, at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (neck stiffness), PAIN (body ache), INSOMNIA (unable to sleep all night), PERIARTHRITIS (Frozen shoulder), CHILLS (chills), PYREXIA (FEVER), HEADACHE (headache), PRURITUS (itching head) and VACCINATION SITE PAIN (injection site pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received on 21-Jul-2021 and included New event Frozen shoulder was added, New treatment drug was addded and Outcome of all the events were updated to unknown to recovered.
During his 15min waiting period after receiving the Moderna COVID19 vaccine, patient got somewhat anxious... tachycardic, htn, wobbly knees, felt unwell. Didn't want any intervention, but agreed to lay down. While resting, BP down to 135/65, HR to 89, looked better and calm but then after 10-15min complained that his throat felt itchy. Then said he was allergic to peanuts, but only when eaten in lg quantities. No signs of anaphylaxis, but was sent to ER for evaluation and obs. Left ER w/o getting seen.
Woke up around 2am with intense upper abdominal pain that wasn't subsiding, did not feel like any digestive type issue. Made it very difficult to try and get ready to go to ER so realized I probably couldn't drive myself, took Tylenol and after a while (45min-ish?) it subsided enough that I could go back to sleep.
2 weeks after your second dose I had- fatigue, dizziness, double vision, vertigo. Driving home work from I had terrible double vision two weeks after the shot. I was nauseous and stuck to the couch. I had a migraine. I went to the ER. I still can't hold myself up for a long time.
pt recv vax 18OCT96 & shortly thereafter pt devel knots behind ear & on lt side of jaw;over the course of a wk knots got smaller, but other appeared on head down back of neck & on chest;felt to have lymphadenopathy;
runny nose; tested positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose) and COVID-19 (tested positive for Covid) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048421A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced RHINORRHOEA (runny nose) and COVID-19 (tested positive for Covid). At the time of the report, RHINORRHOEA (runny nose) and COVID-19 (tested positive for Covid) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication use was provided by the reporter. No treatment of events was reported.
itchiness below the injection site; redness below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness below the injection site) and VACCINATION SITE ERYTHEMA (redness below the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 07-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness below the injection site) and VACCINATION SITE ERYTHEMA (redness below the injection site).   At the time of the report, VACCINATION SITE PRURITUS (itchiness below the injection site) and VACCINATION SITE ERYTHEMA (redness below the injection site) was resolving. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Rash and Sore Throat. Prednisone given for the rash.
Large patch involving most of L upper arm and shoulder: erythema, warm, raised, irregular borders, sharply demarcated with underlying induration; itches. Given scripts-will report in 2 days.
Patient was requesting a few vaccines, ultimately settling on TDAP and pneumonia 20. However, rsv and tdap was written on the release form, and given at administration. This was his 2nd rsv vaccination in just over a month.  the patent realized the mistake the next day. The patient reports no adverse reaction.
PATIENT STATED THAT EVER SINCE SHE GOT THE FLU SHOT THAT HER ARM IS VERY SORE AND SHE CAN NOT LIFT HER LEFT ARM AT ALL.